Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis

Abstract excerpt

BACKGROUND: The expression of SMAD4, the central component of the transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signalling pathways, is lost in 50% of pancreatic cancers and is associated with a poor survival. Although the TGF-β pathway has been extensively studied and characterised in pancreatic cancer, there is very limited data on BMP signalling, a well-known tumour-suppressor...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Cells and Metastasis
• Share to Pancreatic and Hepatic Oncology Research
• Share to TGF-β signaling in diseases